Related Experiment Videos

Prevention comes of age?

Luc G A Bonneux¹, Ben A van Hout, Johannes J M van Delden

¹Julius Center for Health Sciences and Primary Care. l.bonneux@jc.azu.nl

European Journal of Epidemiology

|February 5, 2004

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing-Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making Approach.

Advances in therapy·2021

Mapping EQ-5D-3L to EQ-5D-5L.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2021

Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK.

Journal of market access & health policy·2018

The Importance of Economic Perspective and Quantitative Approaches in Oncology Value Frameworks of Drug Selection and Shared Decision Making.

Journal of managed care & specialty pharmacy·2017

Modelling the cost-effectiveness of combination therapy for early, rapidly progressing rheumatoid arthritis by simulating the reversible and irreversible effects of the disease.

BMJ open·2015

Assessing uncertainties surrounding combined endpoints for use in economic models.

Medical decision making : an international journal of the Society for Medical Decision Making·2014

See all related articles